Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,122.6
-13.4 (-0.43%)

 

  • STI Straits Times Index
    3,122.6
    -13.4 (-0.43%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,594.6
    -8.2 (-0.51%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    26,270.0
    38.5 (0.15%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,880.3
    0.3 (0.01%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    20,618.6
    -58.7 (-0.28%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,253.0
    -42.8 (-0.68%)
    Index delayed 10 minutes
  • KOR KOSPI
    1,964.7
    4.4 (0.22%)
    Index delayed 20 minutes
  • XAO XAO
    6,572.6
    -54.8 (-0.83%)
     

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 692.8M
  • Value: 977.8M
  • Rise: 147
  • Fall: 136
  • Unch: 553

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
ThaiBev0.925+0.035
YZJ Shipbldg SGD0.965-0.005
Spackman0.013-0.002
ESR-REIT0.520+0.010
Y Ventures0.101+0.008
Synagie0.168+0.008
Rex Intl0.077+0.001
SingTel3.190-0.030
Mapletree Com Tr2.080+0.010
Ascott Reit1.290-0.010

World Indices

World Indices
Name Last Change
Nasdaq 7,948.6 -54.2
HSI 26,270.0 +38.5
HSCEI 10,177.3 +44.5
Jakarta 6,253.0 -42.8
Nikkei 225 20,618.6 -58.6
SSE Comp 2,880.3 +0.3
Shanghai A 3,017.4 +0.3
Shanghai B 264.8 +0.2
PSE Comp 0.0
KOSPI 1,964.7 +4.4

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

CT ENTERPRISE CT ENTERPRISE
Quotes 15 Minutes Delayed. Updated at 21 Aug 2019 16:08
Last (HKD): 1.580 Change: +0.010 High: 1.590 Remarks: -
Change (%): +0.64 Low: 1.510
Open 1.510 Yesterday's Close 1.570
Buy Price 1.580 Sell Price 1.640
Buy Volume ('000) 0.5 Sell Volume ('000) 0.5
Cumulative Volume ('000) 15.46 Cumulative Value 23,473
Click to show Stock Prices chart

Key Statistics

EPS (HKD) a 0.68908 Trailing EPS (HKD) e 0.59456 NAV (HKD) b 6.4001
PE a 2.293 Trailing PE f 2.657 Price / NAV b 0.2469
Dividend (HKD) d - Cash In Hand (HKD) g 1.1986 Issued & Paid-up Shares c 240,718,000
Dividend Yield (%) d - Price / Cash In Hand g 1.318 Treasury Shares h -
Beta - 75 Daysi 0.697 R-Squared - 75 Days(%)i 8.16 Market Cap (M) 380.334
Beta - 500 Daysi 0.589 R-Squared - 500 Days (%)i 4.62 Enterprise Value (M) 377.670
Piotroski F Score 5 Exchange Code 3839 Par Value ( USD ) 0.10000
52 Weeks Volatility (%) 25.87 6-Month VWAP 1.876 Free Float (%) 26.7
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 29 Jul 2015.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 29 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference CT ENTERPRISE HKEx 380.334 2.293 2.657 0.2469 -
Industry Biotechnology HKEx 50,290.483 13.381 14.021 6.0641 2.711
Local Peer AMGEN-T HKEx 599,701.000 9.116 9.612 7.1115 4.345
Local Peer SINO BIOPHARM HKEx 131,066.541 12.232 12.556 3.7812 0.702
Local Peer WUXI BIO HKEx 102,428.700 137.137 235.356 - -
Local Peer BEIGENE HKEx 68,792.584 - - 5.6668 -
Local Peer GENSCRIPT BIO HKEx 33,814.102 203.359 203.355 9.0227 -
Local Peer 3SBIO HKEx 32,796.835 21.680 21.680 3.3386 -
Local Peer FRONTAGE HKEx 7,127.122 80.902 80.896 20.8578 -
Local Peer HAOHAI BIOTEC HKEx 5,857.658 11.930 13.222 1.3791 1.598
Local Peer VIVA BIOTECH HKEx 5,925.292 55.243 55.246 20.6648 -
Local Peer ASCLETIS-B HKEx 4,606.036 - - 1.1785 -
Local Peer CKLIFE SCIENCES HKEx 3,604.151 13.706 13.687 0.8633 2.667
Local Peer ESSEX BIO-TECH HKEx 2,992.432 12.949 11.432 2.8458 -
Other Local Peers LEE'S PHARM (HKEx), UNI-BIO GROUP (HKEx), BBI LIFE SCI (HKEx), REGENT PACIFIC (HKEx), BIOSINO BIO-TEC (HKEx), EXTRAWELL PHAR (HKEx), HAO WEN HLDGS (HKEx)
Global Peer AMGEN INC NASDAQ 121,841.252 14.515 15.311 11.2878 2.728
Global Peer GILEAD SCIENCES INC NASDAQ 80,343.588 14.728 13.492 3.5525 3.638
Global Peer CSL ASX 106,623.607 39.742 39.742 14.2485 1.138
Global Peer CELGENE CORP NASDAQ 67,514.668 16.687 12.809 6.7172 -
Global Peer VERTEX PHARMACEUTICAL NASDAQ 47,222.470 22.526 21.320 9.3142 -
Global Peer BIOGEN INC NASDAQ 42,658.902 9.628 8.058 3.2934 -
Global Peer ILLUMINA INC NASDAQ 41,843.550 50.658 44.609 9.6592 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 32,532.024 13.309 15.722 3.3346 -
Global Peer ALEXION PHARMACEUTICAL INC NASDAQ 24,985.615 321.978 18.735 2.4584 -
Global Peer AGILENT TECHNOLOGIES INC NYSE 22,473.422 71.119 20.964 4.7342 0.843
Other Global Peers INCYTE CORPORATION (NASDAQ), EXACT SCIENCES CORP (NASDAQ), BIOMARIN PHARMACEUTICAL (NASDAQ), SEATTLE GENETICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), BIO-TECHNE CORP (NASDAQ), EXELIXIS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), REPLIGEN CORP (NASDAQ), MODERNA INC (NASDAQ), Lonza (SGX), ACADIA PHARMACEUTICALS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), FIBROGEN INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), SPARK THERAPEUTICS INC (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), ALKERMES PLC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), TILRAY INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), GENOMIC HEALTH INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ACCELERON PHARMA (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), UNIQURE N.V. (NASDAQ), NATERA INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), AUDENTES THERAPEUTICS INC (NASDAQ), INSMED INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), EDITAS MEDICINE INC (NASDAQ), EPIZYME INC (NASDAQ), OPKO HEALTH INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), VERACYTE INC (NASDAQ), INTREXON CORP (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), ALECTOR INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), OMEROS CORP (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), CYTOKINETICS INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), ALDER BIOPHARMACEUTICALS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), ARVINAS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), RETROPHIN INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), MACROGENICS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), CORTEXYME INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), UROGEN PHARMA LTD (NASDAQ), MORPHIC HOLDING INC (NASDAQ), POLYNOVO LIMITED (ASX), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), ACHILLION PHARMACEUTICALS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), NEXTCURE INC (NASDAQ), PERSONALIS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), SYNTHORX INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), AVITA MEDICAL LTD (ASX), INTRA-CELLUAR THERAPIES INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), MESOBLAST LTD (ASX), SYROS PHARMACEUTICALS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), DERMIRA INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), SINOVAC BIOTECH (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), IMMUNOGEN INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), MEDICINOVA INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), AGENUS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), AVID BIOSERVICES INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), RESTORBIO INC (NASDAQ), XBIOTECH INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), KADMON HLDGS INC (NYSE), ARCUS BIOSCIENCES INC (NYSE), NEXT SCIENCE LTD (ASX), CLOVIS ONCOLOGY INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), PROTHENA CORP PLC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), STARPHARMA HOLDINGS LIMITED (ASX), SORRENTO THERAPEUTICS INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), GERON CORP (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), COMPUGEN (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), TELIX PHARMACEUTIC (ASX), MANNKIND CORPORATION (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), DPHARMA (Bursa), KAMADA (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), CHIASMA INC (NASDAQ), ATHERSYS INC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), 22ND CENTURY GROUP INC (NYSE American), GALECTIN THERAPEUTICS INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), ARDELYX INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), AFFIMED N V (NASDAQ), NOVAVAX INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), PFENEX INC (NYSE American), NABRIVA THERAPEUTICS PLC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), CHIMERIX INC (NASDAQ), XOMA CORP (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), SYNLOGIC INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), LINEAGE CELL THERAPEUTICS INC (NYSE American), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), ENZO BIOCHEM INC (NYSE), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), PALATIN TECHNOLOGIES INC (NYSE American), ALDEYRA THERAPEUTICS (NASDAQ), IMV INC (NASDAQ), STANDARD DIVERSIFIED INC (NYSE American), APTOSE BIOSCIENCES INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), NANTKWEST INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), SESEN BIO INC (NASDAQ), CYNATA THERAPEUTICS LTD (ASX), TOCAGEN INC (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), ADURO BIOTECH INC (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), VERASTEM INC (NASDAQ), SAVARA INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), EDAP TMS S.A. SPON ADS EACH REPR 1 ORD SHARE (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), TREVENA INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), NEON THERAPEUTICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), SELECTA BIOSCIENCES INC (NASDAQ), CEL-SCI CORP (NYSE American), GENOCEA BIOSCIENCES INC (NASDAQ), PORT (SET), VACCINEX INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), COHBAR INC (NASDAQ), ORGENESIS INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), OTONOMY INC (NASDAQ), EQUILLIUM INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), ARAVIVE INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), INFLARX N V (NASDAQ), CURIS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), IBIO INC (NYSE American), IDERA PHARMACEUTICALS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), CORREVIO PHARMA CORP (NASDAQ), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), PLURISTEM THERAPEUTICS INC (NASDAQ), INMUNE BIO INC (NASDAQ), PHYLOGICA LIMITED (ASX), OPIANT PHARMACEUTICALS INC (NASDAQ), NEWLINK GENETICS CORP (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), IMMUTEP LTD (ASX), IMMUTEP LTD SPON ADR EACH REP 100 ORD SHS (NASDAQ), VERMILLION INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), HEMISPHERX BIOPHARMA INC (NYSE American), OUTLOOK THERAPEUTICS INC (NASDAQ), IMUGENE LIMITED (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), IVERIC BIO INC (NASDAQ), FORWARD PHARMA AS SPON ADR EACH REP 2 ORD SHS (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), ORTHOCELL LIMITED (ASX), ARMATA PHARMACEUTICALS INC (NYSE American), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), EVOGENE LTD (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), SENESTECH INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), ZELDA THERAPEUTICS LTD (ASX), CELLDEX THERAPEUTICS INC (NASDAQ), INDIA GLOBALIZATION CAPITAL INC (NYSE American), SIERRA ONCOLOGY INC (NASDAQ), INNOVATE BIOPHARMACEUTICALS INC (NASDAQ), ZAFGEN INC (NASDAQ), RHINOMED LIMITED (ASX), CONTRAFECT CORP (NASDAQ), SOPHIRIS BIO INC (NASDAQ), BIOTRON (ASX), DIAMEDICA THERAPEUTICS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 20 ORD SHS(R/S) (NASDAQ), ONCOSIL MEDICAL LIMITED (ASX), VISTAGEN THERAPEUTICS INC (NASDAQ), AEVI GENOMIC MEDIC (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), BIOCARDIA INC (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), BIOCEPT INC (NASDAQ), MEMPHASYS LTD (ASX), SOLIGENIX INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), VICAL INC (NASDAQ), ORAGENICS INC (NYSE American), HEAT BIOLOGICS INC (NASDAQ), FIBROCELL SCIENCE INC (NASDAQ), HISTOGENICS CORP (NASDAQ), ISORAY INC (NYSE American), PRECIPIO INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), TROVAGENE INC (NASDAQ), ACTINIUM PHARMACEUTICALS INC (NYSE American), CLEVELAND BIOLABS INC (NASDAQ), PATRYS LIMITED (ASX), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), NANOVIRICIDES INC (NYSE American), PROTEOMICS INTL LABORATORIES LTD (ASX), KAZIA THERAPEUTICS LIMITED (ASX), TRACON PHARMACEUTICALS INC (NASDAQ), REGENEUS LTD (ASX), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), CONTANGO ASSET MANAGEMENT LIMITED (ASX), ADALTA LTD (ASX), BIONOMICS LTD (ASX), DARE BIOSCIENCE INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), IMMURON LIMITED (ASX), ANTEO DIAGNOSTICS LIMITED (ASX), Suntar Eco-City^ (SGX), NOVELION THERAPEUTICS INC (NASDAQ), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), CELLMID LIMITED (ASX), ATYR PHARMA INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), PRESCIENT THERAPEUTICS LIMITED (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), ENDRA LIFE SCIENCES INC (NASDAQ), CONATUS PHARMACEUTICALS INC (NASDAQ), VAXART INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), BENITEC BIOPHARMA LTD SPON ADR EA REPR 20 ORD (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), MOTIF BIO PLC ADR EACH REPR 20 SHS SPON (NASDAQ), BENITEC BIOPHARMA LTD (ASX), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), HOLISTA COLLTECH LIMITED (ASX), PHIO PHARMACEUTICALS CORP (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), BIOXYNE LIMITED (ASX), LIVING CELL TECHNOLOGIES (ASX), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), GENETIC TECHNOLOGIES (ASX), CYCLACEL PHARMA IN (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), ARCA BIOPHARMA INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), ADVAXIS INC (NASDAQ), MGRC (Bursa), QT Vascular (SGX), AURIS MEDICAL HOLDING LTD (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), MEGASUN (Bursa), PROTEON THERAPEUTICS INC (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), CCP TECHNOLOGIES LTD (ASX), OPGEN INC (NASDAQ), TBG DIAGNOSTICS LTD (ASX), NANOLLOSE LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), NEURALSTEM INC (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADR EACH REP 20 ORD SHS (NASDAQ), NOVITA HEALTHCARE LTD (ASX), MEDIBIO LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX), TRILLIUM THERAPEUTICS INC (NASDAQ), BPH ENERGY LIMITED (ASX), ALCHEMIA LIMITED (ASX), GENERA BIOSYSTEMS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days ---
10 Days --0.040
-2.47 %
20 Days --0.170
-9.71 %
Medium Term Return 3 Months --0.250
-13.66 %
6 Months --0.450
-22.17 %
1 Year --0.650
-29.15 %
Long Term Return 2 Years --0.540
-25.47 %
3 Years --0.420
-21.00 %
Annualised Return Annualised --
-7.56 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.480 - 2.490 Change From 1 Year Low +0.100 % Change From 1 Year Low (%) +6.76
Change From 1 Year High -0.910 % Change From 1 Year High (%) -36.55
2 Years Range 1.480 - 2.850 Change From 2 Years Low +0.100 % Change From 2 Years Low (%) +6.76
Change From 2 Years High -1.270 % Change From 2 Years High (%) -44.56
5 Years Range 1.480 - 8.000 Change From 5 Years Low +0.100 % Change From 5 Years Low (%) +6.76
Change From 5 Years High -6.420 % Change From 5 Years High (%) -80.25
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Chia Tai Enterprises International Ltd. engages in the manufacturing and sale of chlortetracycline products, trading of machinery and manufacturing and sale of automotive parts. It operates through the following two segments: Biochemical Operation and Industrial Operation. The Biochemical Operation segment manufactures and sells chlortetracycline products. The Industrial Operation segment trades machinery; and produces and markets automotive parts, through the joint venture and associate. The company was founded on October 16, 1987 and is headquartered in Hong Kong.

Historical Price Data

Date Open High Low Close Volume VWAP
21 Aug 2019 1.510 1.590 1.510 1.580 15,460 1.5183
20 Aug 2019 1.540 1.620 1.540 1.570 40,000 1.5470
19 Aug 2019 1.600 1.600 1.600 1.600 - -
16 Aug 2019 1.560 1.600 1.560 1.600 6,500 1.5631
15 Aug 2019 1.500 1.520 1.480 1.520 7,180 1.5000
14 Aug 2019 1.650 1.650 1.510 1.520 91,500 1.5656
13 Aug 2019 1.580 1.600 1.520 1.580 33,100 1.5312
12 Aug 2019 1.660 1.660 1.660 1.660 200 1.9900
09 Aug 2019 1.660 1.660 1.660 1.660 - -
08 Aug 2019 1.660 1.660 1.660 1.660 500 1.6600
07 Aug 2019 1.610 1.620 1.610 1.610 84,360 1.6100
06 Aug 2019 1.620 1.620 1.620 1.620 200 2.0000
05 Aug 2019 1.700 1.740 1.620 1.620 135,400 1.6894
02 Aug 2019 1.680 1.790 1.680 1.750 12,200 1.6969
01 Aug 2019 1.690 1.760 1.690 1.760 12,000 1.7425
31 Jul 2019 1.750 1.750 1.750 1.750 4,000 1.7500
30 Jul 2019 1.710 1.750 1.700 1.750 36,500 1.7021
29 Jul 2019 1.730 1.750 1.730 1.750 24,500 1.7304
26 Jul 2019 1.750 1.800 1.750 1.780 17,500 1.7786
25 Jul 2019 1.750 1.750 1.750 1.750 500 1.7500
24 Jul 2019 1.760 1.780 1.760 1.780 4,040 1.7600
23 Jul 2019 1.780 1.780 1.740 1.750 26,900 1.7606
Summary
Current 2 Weeks
(08 Aug 2019 to 21 Aug 2019)
1.660 1.660 1.480 1.580 194,440 -
Previous 2 Weeks
(25 Jul 2019 to 07 Aug 2019)
1.750 1.750 1.480 1.610 327,160 -
4 Weeks from
(26 Jun 2019 to 24 Jul 2019)
1.750 1.790 1.480 1.780 399,860 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.